Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children
暂无分享,去创建一个
Imti Choonara | Meindert Danhof | Dick Tibboel | D. Tibboel | J. DeJongh | M. Danhof | C. Knibbe | I. Choonara | A. Lynn | E. Krekels | Joost DeJongh | Catherijne Knibbe | Elke H. J. Krekels | Richard A. Lingen | Caroline D. Marel | Anne M. Lynn | R. Lingen | C. Marel
[1] D. Tibboel,et al. Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants. , 2007, British journal of anaesthesia.
[2] D. Tibboel,et al. Efficacy of continuous versus intermittent morphine administration after major surgery in 0–3-year-old infants; a double-blind randomized controlled trial , 2002, Pain.
[3] D. Tibboel,et al. Morphine Glucuronidation in Preterm Neonates, Infants and Children Younger than 3 Years , 2009, Clinical pharmacokinetics.
[4] Dick Tibboel,et al. Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. , 2003, JAMA.
[5] H. Mulla,et al. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. , 2005, British journal of clinical pharmacology.
[6] Imti Choonara,et al. Morphine metabolism in neonates and infants. , 1992 .
[7] M. Levene,et al. Pharmacokinetics of morphine infusion in premature neonates. , 1993, Archives of disease in childhood.
[8] M. Buck. Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation , 2003, Clinical pharmacokinetics.
[9] E. Niclas Jonsson,et al. Erratum to "PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM" [Comput. Methods Prog. Biomedicine 79 (2005) 241-257] , 2005, Comput. Methods Programs Biomed..
[10] K. Olkkola,et al. Kinetics and dynamics of postoperative intravenous morphine in children , 1988 .
[11] V. Fellman,et al. Morphine clearance and effects in newborn infants in relation to gestational age , 2000, Clinical pharmacology and therapeutics.
[12] C. Knibbe,et al. Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children , 2009, European Journal of Clinical Pharmacology.
[13] I. Choonara,et al. Morphine sulphation in children. , 1990, British journal of clinical pharmacology.
[14] A. Merry,et al. Data sharing for pharmacokinetic studies , 2009, Paediatric anaesthesia.
[15] D. Tibboel,et al. Haemofiltration in newborns treated with extracorporeal membrane oxygenation: a case-comparison study , 2009, Critical care.
[16] H. Leufkens,et al. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? , 2009, European Journal of Clinical Pharmacology.
[17] S. Bratton,et al. Clearance of Morphine in Postoperative Infants During Intravenous Infusion: The Influence of Age and Surgery , 1998, Anesthesia and analgesia.
[18] T. Seppälä,et al. Age-related morphine kinetics in infants. , 1993, Developmental pharmacology and therapeutics.
[19] N. Holford,et al. Population clinical pharmacology of children: modelling covariate effects , 2006, European Journal of Pediatrics.
[20] N. Rutter,et al. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions. , 2003, British journal of clinical pharmacology.
[21] E. Niclas Jonsson,et al. PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..
[22] H. Mulla,et al. Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation. , 2003, British journal of clinical pharmacology.
[23] M. Hanekamp. Short and Long Term Studies in Neonates treated with Extracorporeal Membrane Oxygenation (ECMO) , 2005 .
[24] Kelly L. Lundstrom,et al. Morphine pharmacokinetics in premature and mature newborn infants , 1994, Acta paediatrica.
[25] K. Craig,et al. Morphine pharmacokinetics and pain assessment in premature newborns. , 1999, The Journal of pediatrics.
[26] Michel Tod,et al. Facilitation of Drug Evaluation in Children by Population Methods and Modelling , 2008, Clinical pharmacokinetics.
[27] D. Tibboel,et al. Morphine Metabolite Pharmacokinetics during Venoarterial Extra Corporeal Membrane Oxygenation in Neonates , 2006, Clinical pharmacokinetics.
[28] S. Bratton,et al. Intravenous morphine in postoperative infants: intermittent bolus dosing versus targeted continuous infusions , 2000, Pain.
[29] Graham Lawson,et al. Pharmacokinetics of Midazolam in Neonates Undergoing Extracorporeal Membrane Oxygenation , 2003, Anesthesiology.
[30] K. Anand,et al. Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trial. , 2008, British journal of anaesthesia.
[31] France Mentré,et al. Are Population Pharmacokinetic and/ or Pharmacodynamic Models Adequately Evaluated? , 2007, Clinical pharmacokinetics.
[32] J. Slattery,et al. The maturation of morphine clearance and metabolism. , 1992, American journal of diseases of children.
[33] Meindert Danhof,et al. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. , 2009, Drug discovery today.
[34] Paul Chay,et al. Pharmacokinetic‐pharmacodynamic relationships of morphine in neonates , 1992, Clinical pharmacology and therapeutics.
[35] France Mentré,et al. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R , 2008, Comput. Methods Programs Biomed..
[36] R. Lingen. Pain Assessment and Analgesia in the Newborn: An Integrated Approach , 2000 .
[37] D. Tibboel,et al. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. , 2004, British journal of anaesthesia.
[38] D. Tibboel,et al. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates , 2005, Intensive Care Medicine.
[39] France Mentré,et al. Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide , 2006, Pharmaceutical Research.